I. Start the exam by click the “Start” button
Inflammatory bowel disease- Part 5
See all quizzes of Peptic Ulcer Disease at here:
1.With Sulfasalazine therapy, which of the following should be
supplemented ?
A. Iron
B. Folic acid
C. Vitamin B12
D. Pyridoxine
2. Sulfasalazine intolerable side effects are attributable to ?
A. Sulfapyridine moiety
B. Sulfasialic moiety
C. Sulfaphenol moiety
D. All of the above
3.Hypersensitivity reactions to Sulfasalazine include all
except ?
A. Hepatitis
B. Thrombocytosis
C. Worsening of colitis
D. Reversible sperm abnormalities
4.Which out of the following mesalamine formulation has
ethylcellulose coating ?
A. Asacol
B. Balsalazide
C. Claversal
D. Pentasa
5. Which of the following is composed of two 5-ASA radicals
linked by an azo bond ?
A. Asacol
B. Balsalazide
C. Claversal
D. Olsalazine
6. 5-ASA agents act within what period of time ?
A. 6 – 12 hours
B. 1 – 7 days
C. 2 – 4 weeks
D. 4 – 6 weeks
7. Treatment of choice in severe UC is ?
A. 5-ASA
B. Azathioprine
C. Metronidazole
D. Oral glucocorticoid
8. Which of the following is false regarding treatment of IBD ?
A. Antibiotics have no role in treatment of active or quiescent UC
B. Glucocorticoids useful in maintenance therapy in UC & CD
C. 5-ASA effective in inducing remission in UC & CD
D. 5-ASA useful in maintaining remission in UC
9.Which of the following side effects of glucocorticoid therapy
in IBD is not related to dose & duration of therapy ?
A. Abdominal striae
B. Subcapsular cataract
C. Osteonecrosis
D. Emotional disturbances
10. First line treatment in active inflammatory, fistulizing and
perianal CD is ?
A. 5-ASA
B. Azathioprine
C. Metronidazole
D. Salicylates
11. First line treatment in active inflammatory, fistulizing and
perianal CD is ?
A. 5-ASA
B. Azathioprine
C. Ciprofloxacin
D. Salicylates
12. Achilles tendinitis and rupture is associated with which of the
following medicines ?
A. Azathioprine
B. Glucocorticoids
C. Ciprofloxacin
D. Metronidazole
13. Active end product of Azathioprine is ?
A. 6-MP
B. Thioinosinic acid
C. Inosinic acid
D. Thioguanic acid
14.Which of the following drugs is used for postoperative
prophylaxis of CD ?
A. 5-ASA
B. Azathioprine
C. Metronidazole
D. Salicylates
15.Which of the following statements about azathioprine use in
IBD is false ?
A. Pancreatitis as a side effect is completely reversible on
stopping drug
B. Thiopurine methyltransferase is the enzyme responsible for
its metabolism
C. No increased risk of cancer in IBD patients chronically taking
azathioprine
D. Leukopenia is dose-related and delayed
16. Methotrexate (MTX) inhibits which of the following ?
A. Dihydrofolate reductase
B. HMG-CoA reductase
C. Trypanothione reductase
D. Fumarate reductase
17. Potential toxicities of Methotrexate include all except ?
A. Leukopenia
B. Hepatic fibrosis
C. Hypersensitivity pneumonitis
D. Cholelithiasis
18. Which of the following drugs is a lipophilic peptide ?
A. Azathioprine
B. Methotrexate
C. Cyclosporine
D. Tacrolimus
19.Cyclosporine (CSA) acts by inhibition of ?
A. IL-1
B. IL-2
C. IFN-
D. All of the above
20. Which of the following is not a side effect of Cyclosporine
therapy ?
A. Hypertension
B. Gingival hyperplasia
C. Alopecia
D. Paresthesias
21. Seizures may complicate Cyclosporine therapy if there is ?
A. Hypocholesterolemia
B. Hypercholesterolemia
C. Hypertriglyceridemia
D. All of the above
22. Opportunistic infection that commonly occurs with
Cyclosporine therapy is ?
A. Pneumocystis carnii infection
B. M. tuberculosis infection
C. Klebsiella infection
D. Pseudomonas infection
23. Severe UC patients that are refractory to IV glucocortcoids,
should be treated with ?
A. IV Cyclosporine
B. Oral cyclosporine
C. Azathioprine
D. 6 Mercaptopurine
24.Tacrolimus has a mechanism of action similar to ?
A. Methotrexate
B. Cyclosporine
C. Mycophenolate mofetil
D. Thalidomide
25. Which of the following drugs is a macrolide antibiotic ?
A. Azathioprine
B. Methotrexate
C. Cyclosporine
D. Tacrolimus
26. First biologic therapy approved for Crohn’s disease was ?
A. Adalimumab
B. Infliximab
C. Natalizumab
D. Etanercept
27. Infliximab is ?
A. IgG1 chimeric monoclonal antibody against TNF
B. IgG1 fully human monoclonal antibody against TNF
C. IgG4 chimeric monoclonal antibody against TNF
D. P75 TNF receptor fusion protein